Khloris Biosciences has a total of 13 patents globally, out of which no patents have been granted. Of these 13 patents, more than 76% patents are active. United States of America is where Khloris Biosciences has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Khloris Biosciences.
Khloris Biosciences was founded in the year 2017. Khloris Biosciences is a biotechnology company based in the Bay Area dedicated to revolutionizing medical treatment of cardiovascular.
Do read about some of the most popular patents of Khloris Biosciences which have been covered by us in this article and also you can find Khloris Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Khloris Biosciences patent portfolio.
How many patents does Khloris Biosciences have?
Khloris Biosciences has a total of 13 patents globally. These patents belong to 3 unique patent families. Out of 13 patents, 10 patents are active.
How Many Patents did Khloris Biosciences File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Khloris Biosciences Applications Filed | Khloris Biosciences Patents Granted |
2022 | 4 | – |
2021 | 1 | – |
2020 | 2 | – |
2019 | 6 | – |
How many Khloris Biosciences patents are Alive/Dead?
How Many Patents did Khloris Biosciences File in Different Countries?
Countries in which Khloris Biosciences Filed Patents
Country | Patents |
United States Of America | 2 |
Japan | 1 |
Europe | 1 |
Mexico | 1 |
Singapore | 1 |
Canada | 1 |
Hong Kong (S.A.R.) | 1 |
Australia | 1 |
India | 1 |
Where are Research Centres of Khloris Biosciences Patents Located?
The Research Centre for all the Khloris Biosciences patents is the United States of America.
What Percentage of Khloris Biosciences US Patent Applications were Granted?
Khloris Biosciences (Excluding its subsidiaries) has filed 1 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.
Below are the key stats of Khloris Biosciences patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Khloris Biosciences?
Law Firm | Total Applications | Success Rate |
Hdc Ip Law Llp | 1 | 0% |
List of Khloris Biosciences Patents
Khloris Biosciences Patents | Title |
US20230181708A1 | Ipsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer |
US20220387569A1 | Induced Pluripotent Stem Cell-Based Cancer Vaccines |
EP3720482A1 | Ipsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer |
WO2023019000A1 | Ipsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer |
HK40037676A | Ipsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer |
MX2020006944A | Ipsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer. |
IN202047031167A | Ipsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer |
SG11202006160RA | Ipsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer |
AU2018399641A1 | Ipsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer |
CA3087254A1 | Ipsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer |
WO2022256277A1 | Induced Pluripotent Stem Cell-Based Cancer Vaccines |
JP2021509122A | Ipsc-Based Vaccines As Prophylactic And Therapeutic Treatments For Cancer |
WO2019136038A4 | Ipsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer |
What are Khloris Biosciences key innovation segments?
What Technologies are Covered by Khloris Biosciences?
The chart below distributes patents filed by Khloris Biosciences